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Abstract
Current knowledge on obesogenic effects of persistent organic pollutants (POPs) is equivocal. We 
therefore evaluated the associations between early-life POP exposures and body mass index (BMI) 
in 444 Faroese children born in 2007–2009. POPs were measured in maternal 2-week postpartum 
serum and child age-5 serum. Linear regression and generalised linear models assessed the 
associations with continuous and dichotomous BMI z-scores, respectively, at ages 18 months 
and/or 5 years. Maternal serum concentrations of HCB, PFOS and PFOA were associated with 
increased BMI z-scores and/or overweight risk (i.e. BMI z-score≥ 85th WHO percentile). No clear 
association was found for maternal serum-PCBs, p,p’-DDE, PFHxS, PFNA and PFDA. In cross-
sectional analyses, we observed a pattern of inverse associations between child serum-POPs and 
BMI z-scores at age 5, perhaps due to reverse causation that requires attention in future 
prospective analyses. Findings in this recent cohort support a role of maternal exposure to 
endocrine disruptors in the childhood obesity epidemic.
Keywords
developmental toxicity; childhood obesity; endocrine disruptors; perfluoroalkyl substances; 
persistent organic pollutants; DOHaD
1. Introduction
The increasing global obesity trends noted in the past four decades constitute a major public 
health concern (1, 2). If the current trends continue, 70 million preschool children are 
*Corresponding author - contact information: Philippe Grandjean, MD, PhD, Harvard T.H. Chan School of Public Health, 401Park 
Drive Boston, Massachusetts, 02215 United States, Tel: +1 617 384 8907, pgrand@hsph.harvard.edu. 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Conflict of interest: The authors have no competing interests to declare, financial or otherwise.
HHS Public Access
Author manuscript
Reprod Toxicol. Author manuscript; available in PMC 2018 March 01.
Published in final edited form as:
Reprod Toxicol. 2017 March ; 68: 145–153. doi:10.1016/j.reprotox.2016.08.002.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
estimated to be overweight or obese by 2025 (3). Childhood obesity is associated with 
increased risks later in adulthood of obesity and chronic diseases, such as diabetes and 
cardiovascular disease, thus contributing to the leading causes of global morbidity and 
mortality (1, 4, 5). The multifactorial etiology of obesity likely involves an interplay 
between genetic, lifestyle (e.g. diet and physical activity) and environmental factors. 
Growing evidence suggests that exposure to endocrine disruptors during critical windows of 
development may play a role (6–9). Many persistent organic pollutants (POPs), including 
organochlorine compounds (OCs) and perfluoroalkyl substances (PFASs), are known to act 
as endocrine disruptors (10) and are currently hypothesized to be obesogenic.
OCs, such as dichlorodiphenyltrichloroethane (DDT, and its major metabolite DDE) and 
hexachlorobenzene (HCB), have been widely used as pesticides and in industrial 
applications, until their use was gradually banned in developed countries, starting in the 
1970s (11). PFASs are emerging contaminants with oil and water repellent properties used in 
many consumer products and industrial applications (12). Human exposure to POPs occurs 
mainly via ingestion of contaminated food (13, 14), with PFAS exposure also likely 
occurring from ingestion of contaminated water and releases from consumer products (e.g. 
cookware and waterproofed textiles) (12). The half-lives of POPs in adult serum are 
estimated to be 3 to 15 years for OCs (15), 3 to 5 years for legacy PFASs (i.e. 
perfluorooctanesulfonic acid [PFOS] and perfluorooctanoic acid [PFOA]), and 8.5 years for 
perfluorohexanesulfonate (PFHxS) (12), while the half-lives of other emerging PFASs, such 
as perfluorononanoic acid (PFNA) and perfluorodecanoic acid (PFDA), are probably similar 
though uncertain at this point. Human POP exposures begin during early development as the 
mother shares her POP exposures with her child via transplacental transfer and breast milk 
(16–18), and accumulate throughout the lifespan.
Prenatal exposure to DDE has been associated with an elevated body mass index (BMI) in 
infancy and childhood in more than 12 prospective studies, although a few other studies 
reported no clear association (reviewed in (19)). Positive, negative or null associations have 
been reported between prenatal exposure to polychlorinated biphenyls (PCBs) and children’s 
BMI (19–26), while evidence for the potentially obesogenic role of HCB is more limited 
(20, 24, 26–28). Very few of the previous studies also accounted for OC exposures measured 
postnatally (23, 29). The associations of PFAS exposures with weight gain are supported by 
experimental studies (30, 31), but epidemiologic studies have only recently evaluated this 
hypothesis, with inconsistent findings (19, 32–38).
Prenatal exposure to PFOS has been associated with higher weight-for-age in 20-month-old 
girls (35), with lower BMI z-scores in 12-month-old boys (37), and elevated waist-to-height 
ratio in children aged 5–9 years (38), while two other studies reported no association with 
BMI and/or overweight in mid-childhood (33, 36). Prenatal exposure to PFOA has been 
positively associated with child’s BMI gain and body fat (36), and with higher risk of 
obesity in Danish women at 20 years of age (32), whereas one other study, with exposure 
estimates based on residential history and proximity to chemical plants, found no association 
with obesity risk in adulthood (34). Only two studies have evaluated so far exposures to 
emerging PFASs, such as PFHxS and PFNA, and reported non-significant associations with 
childhood obesity (35, 36).
Karlsen et al. Page 2
Reprod Toxicol. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Because the evidence from prospective studies for the suspected obesogenic effects of POPs 
is limited, in particular for emerging PFASs, and because studies assessing POP exposures 
during different windows of development are currently lacking, we evaluated the 
associations of both maternal and child serum-POP concentrations with the risk of childhood 
overweight in a prospective birth cohort study.
2. Methods
2.1 Study population and data collection
A cohort of 490 mother-child pairs was recruited at childbirth, at the National Hospital of 
the Faroe Islands, during an 18-month period between 2007 and 2009, and followed at child 
ages 18 months and 5 years (39, 40). The Faroese are a marine population of mainly 
Scandinavian and Irish origin, with high seafood intakes that contribute to elevated POP 
exposures (41, 42).
Information about sociodemographic characteristics, family medical history, maternal 
prepregnancy BMI and lifestyle factors during pregnancy (including alcohol intake and 
smoking habits) was collected through self-administered questionnaires completed two 
weeks after childbirth. Additional information was extracted from the medical records and 
duration of breastfeeding and the child’s seafood intakes were reported by the mothers at 
later examinations. Biological samples and physical examination information were obtained 
in connection with clinical follow-ups.
This study was approved by the Faroese ethical review committee and the Institutional 
Review Board at Harvard T.H. Chan School of Public Health. All mothers provided written 
informed consent at enrolment and at subsequent clinical examinations.
2.2 Exposure assessment of POPs
Serum-POP concentrations were measured in maternal samples collected at 2 weeks after 
childbirth and in the child’s serum obtained at age 5 years. Samples were stored at −80° C 
until analyses were performed at the University of Southern Denmark.
OC concentrations were measured using gas chromatography with electron capture detection 
as detailed elsewhere (43) and included: HCB, p,p’-DDE and nine major PCB congeners. 
The limit of detection (LOD) for all OCs was 0.03 ng/mL. Concentrations below the LOD 
were substituted by a value equal to half of the LOD. We calculated the sum of PCBs in 
serum (ΣPCBs) as the sum of PCB congeners 138, 153 and 180 multiplied by 2, because 
these are the most commonly detected congeners and represent close to 50% of the total 
serum-PCB concentrations (44). Because OCs are highly lipophilic, concentrations were 
divided by the serum lipid content and expressed in terms of μg/g lipid. The lipid content 
was calculated from cholesterol and triglyceride serum contents (45) as determined by a kit-
based analysis on a Konelab 20 Clinical Chemistry Analyzer (Thermo Fischer Scientific, 
Waltham, MA, USA).
Maternal serum-PFASs concentrations (in ng/mL) were analyzed using liquid 
chromatography with mass spectrometry, as previously described (17). The quantitated 
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substances were PFOS, PFOA, PFHxS, PFNA and PFDA. Concentrations below LOD 
(<0.03 ng/mL) were substituted by half of the LOD.
In a subset of births from this cohort (N=50), we measured POP concentrations also in cord 
blood, and these concentrations correlate closely with the maternal 2-week postpartum 
serum concentrations (Spearman r>0.83 for all measured POPs). Thus, the maternal 
postpartum serum concentrations analysed are considered a proxy of both fetal and early 
postnatal exposures.
2.3 Child anthropometry
The child’s body weight and height were measured at ages 18 months and 5 years by the 
pediatrician of the research team following standard protocols (25). Body weight was 
measured in light clothing using an electronic scale (to the nearest 0,1 kg). Recumbent 
length was measured at 18 months, and standing height was measured without shoes at age 5 
years (to the nearest 0,1 cm). We divided weight by the squared height to calculate BMI (in 
kg/m2). Because physical size varies according to age and sex, we calculated age- and sex-
specific z-scores for BMI using the World Health Organization (WHO) Growth Standards 
(46, 47). Child overweight was classified as a BMI z-score at or above the 85th WHO 
percentile (46, 47).
2.4 Statistical analysis
We analysed 444 mother-child pairs (91% of the original cohort) with measured POP 
concentrations in maternal serum and available BMI of the child at age 18 months. The 
analyses of maternal serum-POPs and child’s BMI at age 5 years included fewer 
observations (N=371, 76% of the original cohort) due to follow-up losses. The cross-
sectional analysis at age 5 included only those children who provided a blood sample 
sufficient for serum-POP analysis (N=349, 71% of the original cohort).
POP concentrations were log10-transformed to normalize the right-skewed distributions. 
Generalized additive models (GAMs) assessed the linearity of dose-response relationships 
between the continuous POP concentrations and outcome variables. Associations between 
maternal serum concentrations of some POPs (i.e. ΣPCBs, PFNA and PFDA) and child’s 
BMI z-scores at 18 months and/or 5 years appeared to be nonlinear (defined as a p-
gain<0.10 in the GAM models) (48), and we therefore report effect estimates both for 
continuous POP concentrations and per tertile of POP concentrations.
The associations between POP concentrations and continuous BMI z-scores were assessed 
using linear regression models, and associations with overweight were analyzed using 
generalized linear models (49). We report effect estimates from both unadjusted and fully 
adjusted models.
We considered a wide range of covariates based on previous findings in the literature: 
maternal nationality, age at delivery, prepregnancy BMI status (defined using the WHO 
cutoffs for adults (50)), gestational weight gain, parity history, maternal smoking, alcohol 
consumption and fish intake during pregnancy, gestational diabetes (based on medical 
registry), type of delivery, and child sex, year of birth, gestational length, preterm birth (i.e. 
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gestational length<37 weeks), birth weight, exclusive breastfeeding duration and fish intake 
at age 5 years. We built multivariable-adjusted models including a set of covariates defined 
by directed acyclic graphs (DAGs). These initial adjusted models for maternal serum-POP 
concentrations included maternal nationality, age at delivery, prepregnancy BMI, gestational 
weight gain, parity, maternal smoking and fish intake during pregnancy, child sex and birth 
weight. The initial adjusted model for the child’s 5-year serum-POP concentrations included 
maternal nationality, age at delivery, prepregnancy BMI, maternal smoking during 
pregnancy, child sex, exclusive breastfeeding duration and the child’s fish intake at age 5 
years. We then evaluated additional potential confounders in the associations of maternal 
serum-POP concentrations (gestational diabetes, maternal alcohol consumption, type of 
delivery, year of birth) or child serum-POP concentrations (year of birth) and the study 
outcomes in the initial adjusted models using forward selection (i.e., adding one variable at 
the time in the model). From those covariates, only the type of delivery changed the 
coefficients for the associations of maternal serum-ΣPCBs, p,p’-DDE, PFHxS and PFNA 
with child’s BMI by more than 10%, and it was therefore retained in all maternal serum-
POP models. The type of delivery is associated with childhood obesity (51) and it could 
conceivably be associated with the maternal postpartum serum-POP concentrations, as 
cesarean compared to vaginal delivery is associated with delayed or unsuccessful initiation 
of breastfeeding (52), which is an important route of POP exposure elimination for the 
mother (17), and increased blood loss that is compensated by blood transfusion of the 
mother in about 4% of cesarean sections (53).
The additional covariates included in the statistical models presented missing values in less 
than 6% of observations (Table 1 shows the results for the analysis of 18-month outcomes 
and Table S1 for the analysis of 5-year outcomes). We first performed complete-case 
analyses (i.e. excluding subjects with missing values from the models). To maximise the 
sample size, we also repeated the analyses after creating a “missing” category in the 
breastfeeding duration covariate, which was the only covariate of those retained in the fully 
adjusted models with missing information. Because the coefficients were similar in 
magnitude and significance to those obtained from the complete-case analyses, we present 
only the results from the analyses using a “missing” category in the covariate of 
breastfeeding.
Previous studies have reported associations of POP exposures with child BMI to be modified 
by child sex (19, 20, 23–25, 26), exclusive breastfeeding duration (24, 26) and maternal 
prepregnancy BMI (20, 24, 25). Thus, we evaluated effect modification by these factors by 
introducing interaction terms (POP exposure*modifier) in the fully adjusted models and 
stratifying models according to potential modifiers.
In sensitivity analyses we reran the statistical models after substituting the lipid-corrected 
OC concentrations (in ng/g lipid) by OC concentrations in ng/mL and including the serum 
lipid content as a separate covariate. Because elimination of POPs in the mother occurs 
during pregnancy through transplacental transfer and accumulation of exposure to the tissues 
of the fetus (16), we considered birth weight as a possible determinant of the maternal serum 
concentration measured after delivery. However, birth weight may likely mediate the 
associations between maternal exposure during pregnancy (that is reflected by the maternal 
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postpartum serum concentrations) to at least some of the POPs and child BMI, and in 
sensitivity analyses we therefore excluded birth weight from the fully adjusted models. 
Further, we repeated the analyses after excluding the 3.2% of the children who were preterm 
births (i.e. <37 weeks of gestation; n=14) and/or had low birth weights (i.e. <2500 gr; n=5), 
as those children would be more prone to catch-up growth during infancy (21). Finally, we 
compared the main characteristics between included and excluded from analysis mother-
child pairs to evaluate the likelihood of selection bias.
Statistical significance level for all associations, including the evaluation of effect modifiers, 
was set as a two-sided p-value less than 0.05. DAGs were drawn using DAGitty version 2.3 
(54). All statistical analyses were conducted using STATA 14.
3. Results
The prevalence of overweight (including obesity) was 15% at age 18 months and 19% at age 
5 years. Overweight compared to normal weight children at age 18 months had higher 
average birth weights (3890 versus 3674 grams) and also higher weights (21.5 versus 19.1 
kg) and heights (112 versus 110 cm) at age 5 years (Table 1). Mothers of overweight infants 
were somewhat younger at the time of delivery (28.8 versus 30.3 years), and more likely to 
have consumed alcohol during pregnancy (10% versus 4%). By the age of 5 years, children 
who were overweight compared to normal weight children (Table S1) were more likely to 
have breastfed for a shorter period (67% versus 50%), and their mothers had gained on 
average more weight during pregnancy (16.3 versus 14.5 kg) and were more likely to have 
smoked during pregnancy (23% versus 14%). Other characteristics did not significantly 
differ according to overweight status at either 18 months or 5 years of age.
The OCs detected in the highest concentrations in both maternal and child serum were the 
major PCB congeners and p,p’-DDE, and the most highly detected PFASs were PFOS and 
PFOA (Table 2). Comparable OC concentrations were detected in maternal and child serum, 
whereas all PFASs occurred in higher concentrations in child serum compared to maternal 
serum, except from PFOS for which concentrations were almost twice as high in maternal 
serum collected five years earlier. In regard to maternal serum concentrations, Pearson 
correlation coefficients ranged from 0.62 to 0.83 among the OCs, with the highest 
correlation shown between ΣPCBs and p,p’-DDE, and from 0.40 to 0.85 among the PFASs, 
with the highest correlation shown between PFNA and PFDA (Table S2). In regard to child 
serum concentrations, Pearson correlation coefficients ranged from 0.81 to 0.90 among the 
OCs, and from 0.28 to 0.74 among the PFASs (Table S2). Pearson correlation coefficients 
between maternal and child serum POP concentrations were the lowest for PFDA (r=0.25) 
and the highest for p,p’-DDE (r=0.69) (Table S2).
Maternal 2-week postpartum serum-HCB concentrations were associated with increased 
child’s BMI z-scores at 18 months (adjusted β per log10-unit HCB increase: 0.15; 95%CI: 
0.01, 0.30) and at 5 years (adjusted β per log10-unit HCB increase: 0.19; 95%CI: 0.04, 0.34) 
(Table 3). Associations between maternal serum-HCB concentrations and child’s risk of 
overweight were in the same direction as the associations with BMI z-scores but did not 
reach statistical significance (Table 3). Maternal serum-PFOS concentrations were positively 
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associated with BMI z-scores (adjusted β per log10-unit PFOS increase: 0.23; 95%CI: 0.04, 
0.42) and overweight risk (adjusted RR per log10-unit PFOS increase: 1.29; 95%CI: 1.01, 
1.64) at age 18 months, but no association was observed at age 5 years. Marginally 
significant associations in the same direction as those for PFOS were seen for continuous 
PFOA and PFHxS concentrations in regard to the child’s BMI z-scores at age 18 months. 
Further, maternal serum concentrations of PFOA, and less clearly for PFHxS, were 
associated with the child’s risk of overweight at age 5 years (adjusted RR per log10-unit 
PFOA increase: 1.50; 95% CI: 1.01, 2.24). Other POPs were not significantly associated 
with the child’s BMI z-scores or overweight risk at either age, with some evidence of non-
linear inverse associations between maternal serum concentrations of PFNA and PFDA with 
the child’s overweight risk at age 5. The adjusted associations for all POPs (Table 3) were in 
the same direction to those obtained from the unadjusted models (Table S3), and in 
particular for PFASs, the inclusion of additional covariates in the models tented to increase 
the magnitude of the associations.
The cross-sectional analyses at age 5 years revealed a pattern of inverse associations 
between most of the POPs measured in child serum and BMI z-scores or overweight risk, 
both in the unadjusted (Table S4) and in the fully adjusted models (Table 4). In fully 
adjusted models simultaneously adjusted for maternal and child serum POP concentrations 
(data not shown), the prospective and cross-sectional POP associations with child BMI z-
scores or overweight at 5 years did not change substantially from those shown in the single 
time-point exposure models.
Child sex, exclusive breastfeeding duration or maternal prepregnancy BMI did not modify 
the associations of either maternal or child serum POP concentrations and child BMI z-
scores (p for interactions tested in all models>0.20). In sensitivity analyses, associations 
between OCs and child BMI z-scores remained robust when OCs were expressed in terms of 
ng/mL and lipid concentrations were included as a separate covariate in the models (data not 
shown). Further, effect estimates for the associations of maternal serum-POP concentrations 
and child’s BMI or overweight risk did not change substantially after omitting birth weight 
from the statistical models, or after excluding preterm births and/or children with low birth 
weights (data not shown). The mothers of children included compared to those excluded 
from the 5-year examination analyses were older at pregnancy (30.5 versus 27.2 years), 
gained less weight during pregnancy (14.9 versus 16.6 kg), and were less likely to be 
nulliparous (27% versus 40%). However, included and excluded children did not differ 
according to maternal prepregnancy BMI, birth weight and other characteristics (Table S5).
4. Discussion
In this prospective birth cohort study from the Faroe Islands, we evaluated a wide range of 
POP exposures and observed positive associations between maternal postpartum serum 
concentrations of HCB, PFOS and PFOA in regard to the child’s BMI z-scores at ages 18 
months and/or 5 years. Maternal serum-HCB concentrations were associated with increases 
in the child’s risk for overweight at either age, although not reaching statistical significance, 
and maternal serum concentrations of PFOS and PFOA were significantly associated with 
increased risks for overweight at age 18 months and 5 years, respectively. Other measured 
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POPs (p,p’-DDE, ΣPCBs, PFHxS, PFNA and PFDA) were more weakly correlated with 
child BMI z-scores and/or overweight risk. Associations were not found to be influenced by 
child sex, duration of breastfeeding, and maternal prepregnancy BMI. In addition, they 
remained robust after adjustment for the child’s serum-POP concentrations at age 5. 
Contrary to the positive associations shown for maternal serum, the cross-sectional analyses 
at age 5 showed a pattern of mainly inverse associations between child serum-POP 
concentrations and the concomitant BMI z-scores or overweight risk.
Cord serum-POP concentrations measured in a subset of births from this cohort were highly 
correlated to maternal 2-week postpartum serum concentrations, and high correlations have 
been also reported between POP concentrations in early pregnancy maternal serum and cord 
serum (18, 55). Therefore, the maternal postpartum serum concentrations in our study likely 
reflect early developmental exposure levels. Our findings are consistent with those of some 
previous birth cohort studies, though not all. Prenatal HCB exposure has been associated 
with the risk for overweight at 14 months (24), at 4 years (20) and 6.5 years of age (27) in 
previous studies with higher concentrations detected in maternal and/or cord serum. 
However, two other studies have reported no association between prenatal HCB exposures 
and obesity outcomes in childhood (26, 28). Differences in the levels of exposure could 
explain, at least in part, the inconsistencies in findings across studies. In the previous 
Faroese Cohort 3 (N=656), prenatal PCB and p,p’-DDE exposures were associated with 
increased BMI z-scores at ages 5–7 years in girls of overweight mothers, though not in boys 
or children of mothers with normal prepregnancy BMIs (25). The lack of replication in this 
most recent Faroese Cohort could be due to the decreased ranges and lower averages of OC 
exposures and/or the smaller sample size that reduces power for detecting significant 
associations, and in particular interactions.
The positive association we found between maternal serum-PFOS concentrations and child 
BMI z-scores at 18 months is in agreement with the positive association reported for 
prenatal PFOS exposure and weight-for-age in 20 month-old British girls (35). In our study, 
this association did not persist at age 5, which is in agreement with the findings of three 
previous studies that did not observe significant associations with child BMI and/or 
overweight risk at mid- and late- childhood (33, 36, 38). Further, two of these studies found 
no clear association between prenatal exposure to PFOA and childhood overweight (33, 38), 
while the other study showed a positive association between PFOA and the child’s BMI 
(36), in agreement with the positive association with overweight risk at age 5 years reported 
in the present study. Although the moderate to high correlations shown between PFOS and 
PFOA in this and other studies do not allow us to identify their relative contributions to the 
associations, the findings of this study may suggest that PFOS associations with obesity 
primarily appear in early childhood, while PFOA associations become apparent at later ages. 
The continuous follow-up of the Faroese cohort will hopefully permit us to elucidate 
whether the associations persist at later life stages. Other emerging PFASs (PFHxS and 
PFNA) have been assessed in only two previous prospective studies reporting non-
significant associations with child obesity outcomes (35, 36), which is in agreement with our 
findings.
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The child’s age-5 serum-POP concentrations were not associated with increases in child 
BMI and did not affect the associations of maternal serum-POP concentrations, thus 
suggesting that exposure during fetal and/or perinatal life may be the most critical window 
of susceptibility. The inverse cross-sectional associations observed for POPs and child BMI 
z-scores at age 5 years may likely be due to reverse causation associated with the expanded 
distribution volumes in obese compared to lean children, or unmeasured confounding and 
the lack of adequate adjustment for child’s dietary habits and physical activity. One previous 
study similarly reported postnatal PCB153 exposure, estimated based on pharmacokinetic 
models, to be negatively associated with child growth at age 2 years, while null associations 
were reported for prenatal PCB153 exposure (29). The differences in findings between 
maternal and child serum concentrations in our study highlight that conclusions based on 
cross-sectional associations involve caveats, as the findings may not reflect prospective 
associations. As the children are growing older, the prospective evaluation of the 
associations between the measured child’s serum-POP concentrations and subsequent 
changes in children’s BMI at later ages may help to broaden the understanding of the role of 
postnatal POP exposures on children’s growth.
The maternal serum-OC concentrations in this Faroese population were generally lower than 
those reported in previous birth cohort studies (23, 26, 27). The decrease in OC 
concentrations throughout recent decades is likely due to the decreased use of OCs in 
Western countries since the 1970s (11). Similarly, maternal serum-PFOA and serum-PFOS 
concentrations were lower than those reported in some previous studies (32, 33, 35, 36). 
Maternal serum-PFHxS concentrations were also somewhat lower in our study compared to 
the concentrations reported previously in US and British pregnant women (35, 36), while 
PFNA concentrations were higher in the Faroese population than those reported previously 
in a Danish birth cohort (32). Increasing trends of PFNA and PFHxS concentrations from 
1999 to 2008 have been noted in a previous study using data from the National Health and 
Nutrition Examination Survey (NHANES) (56). Therefore, prospective evidence on the 
health effects of these emerging PFASs is currently much needed.
The high participation rate at the follow-up examinations, the wide variety of POPs 
measured in serum of both the mothers and their children, and the minimal influence of 
numerous evaluated confounders, are important strengths of this study. One other strength is 
the low detection limits of the analytical methods for the quantification of serum POPs, 
which allowed almost complete quantification of the concentrations of all POPs, including 
those of emerging PFASs (>93% of analysed samples). The Faroese population is fairly 
homogeneous in regard to nationality and socioeconomic factors, and the likelihood of 
residual confounding is therefore reduced compared to other settings. Regardless of the 
differences in maternal age, gestational weight gain and parity, included and excluded 
children did not differ in regard to major determinants of child’s BMI, such as maternal BMI 
status and birth weight, and any important selection bias is therefore unlikely. However, we 
cannot rule out the possibility that correlated exposures to other unmeasured prenatal and/or 
postnatal endocrine disruptors may confound the associations. Study limitations include the 
somewhat modest sample size that reduces the power, and the lack of detailed information 
on child’s diet and physical activity that may have confounded the cross-sectional 
associations shown at age 5 years. However, the associations were robust after controlling 
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for maternal and child’s fish consumption that represents a major source of POP exposures 
in the Faroe Islands (41, 42) and may also affect the child’s growth. Finally, the possibility 
of chance findings due to multiple comparisons may need to be considered.
5. Conclusions
In this Faroese birth cohort born in 2007–2009, we found positive prospective associations 
between maternal serum concentrations of HCB, PFOS and PFOA and BMI z-scores and/or 
overweight risk in preschool children. Other measured POPs (p,p’-DDE, PCBs, PFHxS, 
PFNA and PFDA) were not significantly associated with child’s BMI or risk for overweight. 
These findings support the suspected contribution of early-life exposures to endocrine 
disruptors in the global obesity epidemic. The pattern of inverse associations between 
serum-POP concentrations and BMI z-scores observed in cross-sectional analyses at age 5 
years highlight the importance of evaluating these associations in prospective cohort studies.
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Table 3
Adjusted associations of POPs in maternal 2-week postpartum serum with child BMI z-scores and overweight 
at ages 18 months and 5 years.
Maternal serum POP Child outcomes at 18 months
N=444
Child outcomes at 5 years
N=371
BMI z-score Overweight BMI z-score Overweight
β (95%CI)a RR (95% CI)a β (95%CI)a RR (95% CI)a
HCB (μg/g-lipid)
 Per log-10 unit increase 0.15 (0.01, 0.30)** 1.11 (0.92, 1.34) 0.19 (0.04, 0.34)** 1.46 (0.95, 2.24)*
 <0.01 Reference Reference Reference Reference
 0.01–0.02 0.06 (−0.14, 0.26) 1.06 (0.83, 1.36) 0.00 (−0.20, 0.21) 0.84 (0.46, 1.52)
 >0.02 0.21 (0.01, 0.41)** 1.09 (0.84, 1.40) 0.25 (0.05, 0.46)** 1.30 (0.77, 2.18)
ΣPCBs (μg/g-lipid)
 Per log-10 unit increase −0.01 (−0.12, 0.09) 0.98 (0.86, 1.11) 0.05 (−0.06, 0.16) 1.24 (0.92, 1.67)
 <0.30 Reference Reference Reference Reference
 0.30–0.66 −0.14 (−0.34, 0.06) 0.90 (0.70, 1.15) −0.01 (−0.22, 0.19) 0.82 (0.44, 1.52)
 >0.66 −0.06 (−0.26, 0.15) 0.95 (0.74, 1.21) 0.10 (−0.11, 0.31) 1.59 (0.95, 2.66)*
p,p’-DDE (μg/g-lipid)
 Per log-10 unit increase 0.01 (−0.07, 0.09) 0.97 (0.88, 1.08) 0.05 (−0.04, 0.13) 1.17 (0.93, 1.47)
 <0.09 Reference Reference Reference Reference
 0.09–0.22 0.11 (−0.08, 0.31) 0.96 (0.76, 1.22) 0.07 (−0.13, 0.27) 0.97 (0.56, 1.67)
 >0.22 0.05 (−0.15, 0.26) 1.03 (0.80, 1.31) 0.14 (−0.06, 0.35) 1.32 (0.79, 2.22)
PFOS (ng/mL)
 Per log-10 unit increase 0.23 (0.04, 0.42)** 1.29 (1.01, 1.64)** 0.04 (−0.15, 0.22) 1.01 (0.58, 1.75)
 <6.83 Reference Reference Reference Reference
 6.83–9.68 0.08 (−0.12, 0.28) 1.05 (0.82, 1.34) 0.06 (−0.15, 0.26) 1.13 (0.68, 1.87)
 >9.68 0.20 (0.01, 0.40)** 1.24 (0.98, 1.57)* −0.01 (−0.22, 0.19) 0.94 (0.53, 1.66)
PFOA (ng/mL)
 Per log-10 unit increase 0.14 (−0.03, 0.31) 1.14 (0.92, 1.40) 0.16 (−0.01, 0.33)* 1.50 (1.01, 2.24)**
 <1.07 Reference Reference Reference Reference
 1.07–1.72 0.11 (−0.09, 0.31) 1.16 (0.91, 1.47) 0.16 (−0.04, 0.37) 1.33 (0.75, 2.35)
 >1.72 0.06 (−0.16, 0.28) 1.10 (0.84, 1.46) 0.11 (−0.11, 0.34) 1.88 (1.05, 3.35)**
PFHxS (ng/mL)
 Per log-10 unit increase 0.10 (−0.01, 0.21)* 1.12 (0.97, 1.30) 0.04 (−0.07, 0.15) 1.11 (0.77, 1.59)
 <0.16 Reference Reference Reference Reference
 0.16–0.27 −0.03 (−0.23, 0.17) 1.06 (0.82, 1.38) −0.02 (−0.22, 0.19) 0.86 (0.47, 1.55)
 >0.27 0.18 (−0.03, 0.38)* 1.24 (0.97, 1.58)* 0.07 (−0.14, 0.28) 1.22 (0.73, 2.04)
PFNA (ng/mL)
 Per log-10 unit increase 0.01 (−0.19, 0.21) 1.02 (0.79, 1.31) −0.00 (−0.21, 0.20) 1.15 (0.67, 1.98)
 <0.57 Reference Reference Reference Reference
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Maternal serum POP Child outcomes at 18 months
N=444
Child outcomes at 5 years
N=371
BMI z-score Overweight BMI z-score Overweight
β (95%CI)a RR (95% CI)a β (95%CI)a RR (95% CI)a
 0.57–0.79 −0.13 (−0.33, 0.06) 0.80 (0.62, 1.02)* −0.15 (−0.35, 0.05) 0.61 (0.35, 1.06)*
 >0.79 0.01 (−0.19, 0.20) 1.02 (0.81, 1.28) −0.06 (−0.26, 0.14) 1.04 (0.65, 1.66)
PFDA (ng/mL)
 Per log-10 unit increase 0.09 (−0.10, 0.26) 1.14 (0.91, 1.43) −0.04 (−0.23, 0.14) 1.02 (0.61, 1.70)
 <0.22 Reference Reference Reference Reference
 0.22–0.32 −0.07 (−0.27, 0.13) 0.90 (0.71, 1.15) −0.14 (−0.34, 0.06) 0.51 (0.29, 0.88)**
 >0.32 0.06 (−0.14, 0.26) 1.03 (0.82, 1.31) −0.07 (−0.27, 0.13) 0.86 (0.55, 1.36)
**
P-value<0.05;
*
P-value≥0.05 and <0.10.
aAll models are adjusted for maternal nationality, age at delivery, prepregnancy BMI, gestational weight gain, parity, smoking during pregnancy, 
maternal fish intake during pregnancy, type of delivery, child sex and birth weight.
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Table 4
Adjusted cross-sectional associations of POPs in child serum with child BMI z-scores and overweight at age 5 
years.
Child serum POP Child outcomes at 5 years
N=349
BMI z−score Overweight
β (95%CI)a RR (95% CI)a
HCB (μg/g-lipid)
 Per log-10 unit increase
−0.26 (−0.45, −0.06)** 0.65 (0.39, 1.08)
 <0.02 Reference Reference
 0.02–0.03 −0.14 (−0.36, 0.09) 0.88 (0.52, 1.48)
 >0.03
−0.30 (−0.52, −0.07)** 0.56 (0.31, 1.03)*
ΣPCBs (μg/g-lipid)
 Per log-10 unit increase
−0.13 (−0.22, −0.04)** 0.83 (0.67, 1.02)*
 <0.29 Reference Reference
 0.30–0.70 −0.10 (−0.32, 0.12) 0.85 (0.49, 1.51)
 >0.70
−0.39 (−0.61, −0.16)** 0.66 (0.37, 1.19)
p,p’-DDE (μg/g-lipid)
 Per log-10 unit increase −0.06 (−0.15, 0.03) 0.92 (0.74, 1.15)
 <0.13 Reference Reference
 0.13–0.31 −0.02 (−0.24, 0.21) 0.75 (0.40, 1.39)
 >0.31 −0.09 (−0.32, 0.14) 0.90 (0.52, 1.55)
PFOS (ng/mL)
 Per log-10 unit increase
−0.21 (−0.44, 0.02)* 0.68 (0.36, 1.29)
 <3.87 Reference Reference
 3.87–5.58 −0.16 (−0.38, 0.07) 0.68 (0.38, 1.21)
 >5.58 −0.16 (−0.39, 0.07) 0.87 (0.51, 1.51)
PFOA (ng/mL)
 Per log-10 unit increase
−0.27 (−0.52, −0.02)** 0.68 (0.38, 1.22)
 <1.88 Reference Reference
 1.88–2.55 0.05 (−0.17, 0.27) 0.76 (0.44, 1.31)
 >2.55 −0.14 (−0.36, 0.08) 0.84 (0.48, 1.44)
PFHxS (ng/mL)
 Per log-10 unit increase −0.15 (−0.34, 0.04) 0.73 (0.44, 1.23)
 <0.28 Reference Reference
 0.28–0.39 0.07 (−0.15, 0.30) 1.00 (0.59, 1.70)
 >0.39 −0.12 (−0.35, 0.11) 0.94 (0.54, 1.62)
PFNA (ng/mL)
 Per log-10 unit increase
−0.18 (−0.34, −0.02)** 0.67 (0.45, 1.00)*
 <0.91 Reference Reference
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Child serum POP Child outcomes at 5 years
N=349
BMI z−score Overweight
β (95%CI)a RR (95% CI)a
 0.91–1.44 −0.05 (−0.27, 0.17) 1.15 (0.69, 1.92)
 >1.44
−0.22 (−0.44, 0.01)* 0.70 (0.38, 1.30)
PFDA (ng/mL)
 Per log-10 unit increase
−0.18 (−0.33, −0.02)** 0.64 (0.46, 0.90)**
 <0.28 Reference Reference
 0.28–0.42
−0.22 (−0.44, −0.00)** 0.53 (0.30, 0.94)**
 >0.42
−0.19 (−0.41, 0.02)* 0.58 (0.34, 0.97)**
**
P-value<0.05;
*
P-value≥0.05 and <0.10.
aAll models are adjusted for maternal nationality, age at delivery, prepregnancy BMI, smoking during pregnancy, child sex, exclusive breastfeeding 
duration and child’s fish intake at age 5 years.
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